Skip to content

A Comparison of the Laryngeal Mask Airway (LMA) Proseal and LMA Supreme in Children

A Randomized Trial Comparing the Laryngeal Mask Airway-SupremeTM With the Laryngeal Mask Airway-ProsealTM in Children

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01449656
Enrollment
60
Registered
2011-10-10
Start date
2011-10-31
Completion date
2011-11-30
Last updated
2011-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children

Brief summary

The aim of this randomized prospective study is to compare two laryngeal mask airways with a provision for evacuation of gastric contents, the LMA Proseal and The investigators hypothesize that airway leak pressures with the LMA Proseal will be significantly different (higher) when compared with the LMA Supreme.

Detailed description

The goal of this study is to compare the LMA Proseal and LMA Supreme in children having surgery. The investigators hypothesize that the airway leak pressures with the LMA Proseal will be superior to the LMA Supreme. Airway leak pressures will be measured by recording the circuit pressure at which equilibrium is reached. The ease of placement of the device and gastric tube, fiberoptic grade of laryngeal view, feasibility of use during positive pressure ventilation, and complications (airway related, gastric insufflation, trauma) will also be assessed.

Interventions

DEVICELMA Proseal: control device

LMA Proseal will be placed in children weighing 10-20kg based on a computer generated randomization

LMA Supreme will be placed in children weighing 10-20kg based on a computer generated randomization

Sponsors

Ann & Robert H Lurie Children's Hospital of Chicago
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Months to 6 Years
Healthy volunteers
Yes

Inclusion criteria

* Children undergoing general anesthesia using a supraglottic airway device * weight 10-20 kg * age 6 months-6 years

Exclusion criteria

* ASA class IV, V Emergency procedures * History of a difficult airway * Active gastrointestinal reflux * Active upper respiratory tract infection

Design outcomes

Primary

MeasureTime frameDescription
Airway Leak Pressureparticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursAirway leak pressures will be measured by recording the circuit pressure at which equilibrium is reached when fresh gas flow is delivered at 3L/min when the pressure limiting valve is closed completely.

Secondary

MeasureTime frameDescription
Number of attempts to place the deviceparticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursnumber of attempts needed for successful placement will be recorded (maximum of 3 attempts will be considered as a failure)
Fiberoptic grade of laryngeal viewparticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursThe laryngeal alignment through the devices will be graded using an established scoring system
Gastric insufflationparticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursThe presence of gastric insufflations will be assessed during leak pressure testing by using epigastric auscultation
Ease of gastric tube placementparticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursThe ease of gastric placement will be timed and assessed using a subjective scale
Time to secure the airwayparticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursFrom picking up the airway device to bilateral chest expansion and presence of ETCO2
feasibility of positive pressure ventilationparticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursPeak inspiratory pressure and tidal volumes will be recorded. Maximum peak inspiratory pressure will be the airway leak pressure was determined for each patient
Quality of the airwayparticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursThe quality of hands free anesthesia will be assessed during maintenance of anesthesia using a previously described scale
Adverse effectsParticipants will be followed for the duration of anesthesia and 24 hours postoperativelycomplications such as oxygen desaturations, mucosal trauma, reflex activation of the airway, sore throat, dysphonia will be recorded
Fiberoptic view through the gastric tubeparticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursThe view through the gastric drain tube of the LMA supreme will be assessed and graded using an established scoring system

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026